OBJECTIVE: To identify the clinical parameters associated with increased carotid intima-media thickness (CIMT) in overweight and obese adolescents with type 2 diabetes. METHODS: We studied 27 patients (11 males) with type 2 diabetes. Criteria for selection were age (12-19 years), body mass index above the 95th percentile for age and gender, a positive family history of diabetes, normal or high C-peptide, and negative studies for islet cell antibodies. Age- and gender-matched healthy subjects were selected as the control group. Measurements of CIMT, lipid profile, hypersensitive C-reactive protein, hemoglobin A1C (HbA1C), and insulin resistance by homeostasis model of assessment (HOMA) were obtained for all participants. RESULTS: CIMT was higher in diabetic patients than in healthy subjects (0.68 ± 0.16 vs. 0.58 ± 0.1, p < 0.01). The range of HbA1C in the 15 patients with uncontrolled diabetes was 7.6-10.4 (mean: 8.9 ± 0.9). CIMT, HbA1C, systolic blood pressure, triglycerides, HOMA, and C-reactive protein were significantly higher in patients with uncontrolled than with controlled diabetes. In diabetic patients, CIMT correlated positively with body mass index (p < 0.001), duration of diabetes (p < 0.001), systolic (p < 0.001) and diastolic blood pressure (p < 0.01), HbA1C (p < 0.001), HOMA (p < 0.01), and C-reactive protein (p < 0.01). CONCLUSIONS: CIMT is increased in adolescents with type 2 diabetes. Poor glycemic control, HOMA, increased C-reactive protein, body mass index, duration of diabetes, and elevated blood pressure are associated with early atherosclerosis in these patients.
OBJECTIVE: To identify the clinical parameters associated with increased carotid intima-media thickness (CIMT) in overweight and obese adolescents with type 2 diabetes. METHODS: We studied 27 patients (11 males) with type 2 diabetes. Criteria for selection were age (12-19 years), body mass index above the 95th percentile for age and gender, a positive family history of diabetes, normal or high C-peptide, and negative studies for islet cell antibodies. Age- and gender-matched healthy subjects were selected as the control group. Measurements of CIMT, lipid profile, hypersensitiveC-reactive protein, hemoglobin A1C (HbA1C), and insulin resistance by homeostasis model of assessment (HOMA) were obtained for all participants. RESULTS:CIMT was higher in diabeticpatients than in healthy subjects (0.68 ± 0.16 vs. 0.58 ± 0.1, p < 0.01). The range of HbA1C in the 15 patients with uncontrolled diabetes was 7.6-10.4 (mean: 8.9 ± 0.9). CIMT, HbA1C, systolic blood pressure, triglycerides, HOMA, and C-reactive protein were significantly higher in patients with uncontrolled than with controlled diabetes. In diabeticpatients, CIMT correlated positively with body mass index (p < 0.001), duration of diabetes (p < 0.001), systolic (p < 0.001) and diastolic blood pressure (p < 0.01), HbA1C (p < 0.001), HOMA (p < 0.01), and C-reactive protein (p < 0.01). CONCLUSIONS:CIMT is increased in adolescents with type 2 diabetes. Poor glycemic control, HOMA, increased C-reactive protein, body mass index, duration of diabetes, and elevated blood pressure are associated with early atherosclerosis in these patients.
Authors: Kathy F Yates; Victoria Sweat; Po Lai Yau; Michael M Turchiano; Antonio Convit Journal: Arterioscler Thromb Vasc Biol Date: 2012-09 Impact factor: 8.311
Authors: Zhiqian Gao; Philip R Khoury; Connie E McCoy; Amy S Shah; Thomas R Kimball; Lawrence M Dolan; Elaine M Urbina Journal: Atherosclerosis Date: 2015-12-08 Impact factor: 5.162
Authors: Stefanie R van Mil; L Ulas Biter; Gert-Jan M van de Geijn; Erwin Birnie; Martin Dunkelgrun; Jan N M IJzermans; Noelle van der Meulen; Guido H H Mannaerts; Manuel Castro Cabezas Journal: Obes Surg Date: 2018-08 Impact factor: 4.129
Authors: Amy S Shah; Laure El Ghormli; Samuel S Gidding; Kara S Hughan; Lorraine E Levitt Katz; Dorit Koren; Jeanie B Tryggestad; Fida Bacha; Barbara H Braffett; Silva Arslanian; Elaine M Urbina Journal: Acta Diabetol Date: 2021-09-20 Impact factor: 4.280
Authors: Stephanie T Chung; Lorraine E Levitt Katz; Nicolas Stettler-Davis; Justine Shults; Arthur Sherman; Joon Ha; Darko Stefanovski; Ray C Boston; Daniel J Rader; Sheela N Magge Journal: J Clin Endocrinol Metab Date: 2022-05-17 Impact factor: 6.134
Authors: Amy S Shah; Laure El Ghormli; Samuel S Gidding; Fida Bacha; Kristen J Nadeau; Lorraine E Levitt Katz; Jeanie B Tryggestad; Natasha Leibel; Daniel E Hale; Elaine M Urbina Journal: J Diabetes Complications Date: 2018-05-25 Impact factor: 2.852